Idiopathic thrombocytopenic purpura treatment in a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T cell therapy

The adoptive transfer of CAR-T cells, which are modified T cells expressing chimeric antigen receptors (CARs), to target B cell maturation antigen (BCMA) has demonstrated impressive results in treating relapsed/refractory multiple myeloma. Although BCMA CAR-T therapy induces certain complications in...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Lei, Zhu, Feng, Wei, Guoqing, Wu, Wenjun, Yang, Luxin, Hu, Yongxian, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232090/
https://www.ncbi.nlm.nih.gov/pubmed/32455157
http://dx.doi.org/10.1016/j.reth.2020.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232090/
https://www.ncbi.nlm.nih.gov/pubmed/32455157
http://dx.doi.org/10.1016/j.reth.2020.03.005

Ejemplares similares